421 related articles for article (PubMed ID: 23049525)
41. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
[TBL] [Abstract][Full Text] [Related]
42. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation.
Grant C; Barmak K; Alefantis T; Yao J; Jacobson S; Wigdahl B
J Cell Physiol; 2002 Feb; 190(2):133-59. PubMed ID: 11807819
[TBL] [Abstract][Full Text] [Related]
43. Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection.
Okajima R; Casseb J; Sanches JA
Int J Dermatol; 2013 Jan; 52(1):63-8. PubMed ID: 23278610
[TBL] [Abstract][Full Text] [Related]
44. Human T Cell Leukemia Virus Type 1 and Eye Diseases.
Terada Y; Kamoi K; Komizo T; Miyata K; Mochizuki M
J Ocul Pharmacol Ther; 2017 May; 33(4):216-223. PubMed ID: 28263674
[TBL] [Abstract][Full Text] [Related]
45. STLV-1 as a model for studying HTLV-1 infection.
Jégado B; Kashanchi F; Dutartre H; Mahieux R
Retrovirology; 2019 Dec; 16(1):41. PubMed ID: 31843020
[TBL] [Abstract][Full Text] [Related]
46. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
[TBL] [Abstract][Full Text] [Related]
47. Animals Models of Human T Cell Leukemia Virus Type I Leukemogenesis.
Niewiesk S
ILAR J; 2016; 57(1):3-11. PubMed ID: 27034390
[TBL] [Abstract][Full Text] [Related]
48. High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1.
Primo J; Siqueira I; Nascimento MC; Oliveira MF; Farre L; Carvalho EM; Bittencourt AL
Braz J Med Biol Res; 2009 Aug; 42(8):761-4. PubMed ID: 19578703
[TBL] [Abstract][Full Text] [Related]
49. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
50. p30 protein: a critical regulator of HTLV-1 viral latency and host immunity.
Moles R; Sarkis S; Galli V; Omsland M; Purcell DFJ; Yurick D; Khoury G; Pise-Masison CA; Franchini G
Retrovirology; 2019 Dec; 16(1):42. PubMed ID: 31852501
[TBL] [Abstract][Full Text] [Related]
51. [Human retrovirus HTLV-1: descriptive and molecular epidemiology, origin, evolution, diagnosis and associated diseases].
Gessain A
Bull Soc Pathol Exot; 2011 Aug; 104(3):167-80. PubMed ID: 21796326
[TBL] [Abstract][Full Text] [Related]
52. [New human retroviruses: HTLV-3 and HTLV-4].
Mahieux R; Gessain A
Med Trop (Mars); 2005 Nov; 65(6):525-8. PubMed ID: 16555510
[TBL] [Abstract][Full Text] [Related]
53. Human T-lymphotropic virus 1 (HTLV-1) infection--dermatological implications.
Amano M; Setoyama M; Grant A; Kerdel FA
Int J Dermatol; 2011 Aug; 50(8):915-20. PubMed ID: 21781059
[TBL] [Abstract][Full Text] [Related]
54. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
[TBL] [Abstract][Full Text] [Related]
55. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
[TBL] [Abstract][Full Text] [Related]
56. Isolation and characterization of simian T-cell leukemia virus type II from New World monkeys.
Chen YM; Jang YJ; Kanki PJ; Yu QC; Wang JJ; Montali RJ; Samuel KP; Papas TS
J Virol; 1994 Feb; 68(2):1149-57. PubMed ID: 7507178
[TBL] [Abstract][Full Text] [Related]
57. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
[TBL] [Abstract][Full Text] [Related]
58. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
[TBL] [Abstract][Full Text] [Related]
59. Animal Models Utilized in HTLV-1 Research.
Panfil AR; Al-Saleem JJ; Green PL
Virology (Auckl); 2013; 4():49-59. PubMed ID: 25512694
[TBL] [Abstract][Full Text] [Related]
60. The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family.
Mahieux R; Gessain A
Pathol Biol (Paris); 2009 Mar; 57(2):161-6. PubMed ID: 18456423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
